Recent advances and clinical translation of liposomal delivery systems in cancer therapy

被引:64
作者
Chen, Jiayi [1 ]
Hu, Siyuan [1 ]
Sun, Man [1 ]
Shi, Jianan [1 ]
Zhang, Huan [1 ]
Yu, Hongmei [2 ]
Yang, Zhaogang [1 ]
机构
[1] Jilin Univ, Sch Life Sci, Changchun, Peoples R China
[2] Jilin Univ, China Japan Union Hosp, Changchun, Peoples R China
关键词
Liposome; Cancer; Delivery systems; Combination therapy; Clinical translation; DRUG-DELIVERY; CO-DELIVERY; CATIONIC LIPOSOMES; INDOCYANINE GREEN; BREAST-CANCER; NANOPARTICLES; DOXORUBICIN; EFFICACY; PACLITAXEL; NANOMEDICINES;
D O I
10.1016/j.ejps.2023.106688
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The limitations of conventional cancer treatment are driving the emergence and development of nanomedicines. Research in liposomal nanomedicine for cancer therapy is rapidly increasing, opening up new horizons for cancer treatment. Liposomal nanomedicine, which focuses on targeted drug delivery to improve the therapeutic effect of cancer while reducing damage to normal tissues and cells, has great potential in the field of cancer therapy. This review aims to clarify the advantages of liposomal delivery systems in cancer therapy. We describe the recent understanding of spatiotemporal fate of liposomes in the organism after different routes of drug administration. Meanwhile, various types of liposome-based drug delivery systems that exert their respective advantages in cancer therapy while reducing side effects were discussed. Moreover, the combination of liposomal agents with other therapies (such as photodynamic therapy and photothermal therapy) has demonstrated enhanced tumortargeting efficiency and therapeutic efficacy. Finally, the opportunities and challenges faced by the field of liposome nanoformulations for entering the clinical treatment of cancer are highlighted.
引用
收藏
页数:19
相关论文
共 179 条
[1]   Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release [J].
Aghdam, Marjan Abri ;
Bagheri, Roya ;
Mosafer, Jafar ;
Baradaran, Behzad ;
Hashemzaei, Mahmoud ;
Baghbanzadeh, Amir ;
de la Guardi, Miguel ;
Mokhtarzadeh, Ahad .
JOURNAL OF CONTROLLED RELEASE, 2019, 315 :1-22
[2]   Liposome: classification, preparation, and applications [J].
Akbarzadeh, Abolfazl ;
Rezaei-Sadabady, Rogaie ;
Davaran, Soodabeh ;
Joo, Sang Woo ;
Zarghami, Nosratollah ;
Hanifehpour, Younes ;
Samiei, Mohammad ;
Kouhi, Mohammad ;
Nejati-Koshki, Kazem .
NANOSCALE RESEARCH LETTERS, 2013, 8
[3]   The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs [J].
Akinc, Akin ;
Maier, Martin A. ;
Manoharan, Muthiah ;
Fitzgerald, Kevin ;
Jayaraman, Muthusamy ;
Barros, Scott ;
Ansell, Steven ;
Du, Xinyao ;
Hope, Michael J. ;
Madden, Thomas D. ;
Mui, Barbara L. ;
Semple, Sean C. ;
Tam, Ying K. ;
Ciufolini, Marco ;
Witzigmann, Dominik ;
Kulkarni, Jayesh A. ;
van der Meel, Roy ;
Cullis, Pieter R. .
NATURE NANOTECHNOLOGY, 2019, 14 (12) :1084-1087
[4]   Biocompatible Nanoclusters with High Heating Efficiency for Systemically Delivered Magnetic Hyperthermia [J].
Albarqi, Hassan A. ;
Wong, Leon H. ;
Schumann, Canan ;
Sabei, Fahad Y. ;
Korzun, Tetiana ;
Li, Xiaoning ;
Hansen, Mikkel N. ;
Dhagat, Pallavi ;
Moses, Abraham S. ;
Taratula, Olena ;
Taratula, Oleh .
ACS NANO, 2019, 13 (06) :6383-6395
[5]   Clinical and molecular signature of survival and resistance to olaparib plus pegylated liposomal doxorubicin in platinum-resistant ovarian cancer: a stratified analysis from the phase II clinical trial ROLANDO, GEICO-1601 [J].
Alejandro Perez-Fidalgo, Jose ;
Guerra, Eva ;
Garcia, Yolanda ;
Iglesias, Maria ;
Hernandez-Sosa, Maria ;
Estevez-Garcia, Purificacion ;
Manso Sanchez, Luis ;
Santaballa, Ana ;
Oaknin, Ana ;
Redondo, Andres ;
Rubio, M. Jesus ;
Gonzalez-Martin, Antonio .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (06) :929-936
[6]   Ultrasound-sensitive cRGD-modified liposomes as a novel drug delivery system [J].
AlSawaftah, Nour M. ;
Paul, Vinod ;
Kosaji, Doua ;
Khabbaz, Leen ;
Awad, Nahid S. ;
Husseini, Ghaleb A. .
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2022, 50 (01) :111-120
[7]   Pharmacokinetic evaluation of poorly soluble compounds formulated as nano- or microcrystals after intraperitoneal injection to mice [J].
Aluri, Krishna C. ;
Sigfridsson, Kalle ;
Xue, Aixiang ;
Hariparsad, Niresh ;
McGinnity, Dermot ;
Ramsden, Diane .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 636
[8]   Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches [J].
Ashrafizadeh, Milad ;
Delfi, Masoud ;
Zarrabi, Ali ;
Bigham, Ashkan ;
Sharifi, Esmaeel ;
Rabiee, Navid ;
Paiva-Santos, Ana Claudia ;
Kumar, Alan Prem ;
Tan, Shing Cheng ;
Hushmandi, Kiavash ;
Ren, Jun ;
Zare, Ehsan Nazarzadeh ;
Makvandi, Pooyan .
JOURNAL OF CONTROLLED RELEASE, 2022, 351 :50-80
[9]   DIFFUSION OF UNIVALENT IONS ACROSS LAMELLAE OF SWOLLEN PHOSPHOLIPIDS [J].
BANGHAM, AD ;
STANDISH, MM ;
WATKINS, JC .
JOURNAL OF MOLECULAR BIOLOGY, 1965, 13 (01) :238-+
[10]   Doxil® - The first FDA-approved nano-drug: Lessons learned [J].
Barenholz, Yechezkel .
JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) :117-134